B.1.617.2 enters and fuses lung cells with increased efficiency

The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.617.2, emerged in India and has spread to over 80 countries. B.…

Frontiers Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant

SARS-CoV-2 Life Cycle: Stages and Inhibition Targets

COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation

Frontiers SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms

Covid-19: virology, variants, and vaccines

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation

Dissecting the Unusual Biology of the SARS-CoV-2 Delta Variant

Full article: SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

SARS-COV-2: From Secret Life To Global Pandemic

Frontiers Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation

Delta variant exhibits immune evasion, enhanced cell entry, and augmented syncytium formation